Epigenetic inhibitors for the precision treatment of ARID1A-mutant ovarian cancers: what are the next steps?
Fukumoto T, Zhang R, Bitler BG. Epigenetic inhibitors for the precision treatment of ARID1A-mutant ovarian cancers: what are the next steps? Expert Rev Precis Med Drug Dev. 2018; 3(4):233-236.